---
category: news
title: "AbCellera, tapped by Lilly for its COVID-19 antibody therapy, sets IPO terms with $5B valuation"
excerpt: "Now, itâ€™s going public in the hope of getting more of its antibody work, which includes areas outside of COVID-19, out to partners."
publishedDateTime: 2020-12-07T13:58:00Z
originalUrl: "https://www.fiercebiotech.com/biotech/abcellera-tapped-by-lilly-for-its-covid-antibody-therapy-sets-ipo-terms-5b-valuation"
webUrl: "https://www.fiercebiotech.com/biotech/abcellera-tapped-by-lilly-for-its-covid-antibody-therapy-sets-ipo-terms-5b-valuation"
type: article
quality: 27
heat: 27
published: false

provider:
  name: FierceBiotech
  domain: fiercebiotech.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://qtxasset.com/fiercebiotech/1607352213/Nasdaq-Tower_092614_B.jpg/Nasdaq-Tower_092614_B.jpg?.I9s4nuPOUrPJX3KQtj7p3puS_n83t7S"
    width: 2400
    height: 1600
    isCached: true

secured: "1Qw07DTmmy/PClnly66zjDAf3nIkwroS3oN1t6c88+D3PHisMmPIC7J8F5aj7rZg/BLN545ImjqCxojYjqgS3lMLzvMEuuQoPbEvb2tvjuYRPXQSzOXbFLagiYoFAFf1bp5hG5tm3XdMeQEZl09oHP5+FABZjYkMWHD/qi5g1s3jqTMMEy9D/B0TnDoYnQXaZrIjYnIoHv+j8lQqTVBxIiJELPaCXF9alFR0F6xrwCkwZ57kgqjWe36aU4e0kHJyMygBvfgHpz1ozYscGCGGhRcaf9UEldK0Z5rBN4qsWIPvFTZjWAjYscWg6zKhgGUcMlwJzatRVGcu+JS7cPmknJB4LHuRsc5T7C3OKNsxgIE=;2lLkStMArf2VD+KqfIAD9g=="
---

